== Udvalgte publikationer ==
* Henriksen JH, Lassen NA, Parving H-H, Winkler K. "Filtration as the main mechanism of protein exchange between plasma and the peritoneal cavity in hepatic cirrhosis." ''Scand J Clin Lab Invest'' 40: 503-513, 1980 {{PMID|7444354}}
* Henriksen JH. "Protein-kinetic and haemodynamic studies in patients with liver cirrhosis. Evidence of a lymph-imbalance theory of ascites formation". ''Clin Physiol'' 1: 565-578, 1981. [[doi:10.1111/j.1475-097X.1981.tb00923.x]]
* Henriksen JH, Christensen NJ, Ring-Larsen H. "Noradrenaline and adrenaline in various vascular beds in patients with hepatic cirrhosis". ''Clin Physiol'' 1: 293-304, 1981. [[doi:10.1111/j.1475-097X.1981.tb00898.x]]
* Henriksen JH, Ring-Larsen H, Christensen NJ. "Propranolol in gastrointestinal bleeding from cirrhosis". ''N Engl J Med'' 306: 1551, 1982 {{PMID|6978995}}
*Henriksen JH.: "Permselectivity of the liver blood-lymph (ascitic-fluid) barrier to macromolecules in decompensated cirrhosis. Relation to pore-sizes". ''Clin Physiol'' 3: 163-171, 1983. {{PMID|6682737}}
* Henriksen JH, Ring-Larsen H, Christensen NJ. "Sympathetic nervous activity in cirrhosis". ''J Hepatol'' 1: 55-65, 1984. {{PMID|2997320}}
* Henriksen JH, Schwartz TW, Bülow JB. "Endogenous pancreatic polypeptide in different vascular beds. Relationship to release and degradation in subjects with normal and decreased kidney function". ''Metabolism'' 35: 542-546, 1986. {{PMID|3713514}}
* Henriksen JH, Staun-Olsen P, Mogensen NB, Fahrenkrug J. "Circulating endogenous vasoactive intestinal polypeptide (VIP) in patients with uraemia and liver cirrhosis". ''Eur J Clin Invest'' 16: 211-216, 1986 {{PMID|3089817}}
* Ring-Larsen H, Henriksen JH, Wilken C, Clausen J, Pals H, Christensen NJ. "Diuretic treatment in decompensated cirrhosis and congestive heart failure. Effect of posture". ''Brit. Med J'' 292: 1351-1353, 1986 {{PMID|3085844}}
* Horn T, Christoffersen P, Henriksen JH. "Alcoholic liver injury: Defenestration in non-cirrhotic livers. A scanning electron microscopic study". ''Hepatology'' 7: 77-82, 1987 {{PMID|3542781}}
* Henriksen JH, Tronier B, Bülow JB. "Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting non-diabetic man". ''Metabolism'' 26: 463-468, 1987. {{PMID|3553849}}
* Henriksen JH, Ring-Larsen H. "Raised renal venous pressure: direct cause of renal sodium retention in cirrhosis?" ''Lancet'' 112: ii, 1988. {{PMID|2898690}}
* Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. "Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis". ''Hepatology'' 8: 1151-1157, 1988. {{PMID|2971015}}
* Henriksen JH, Christensen NJ. "Plasma norepinephrine in humans: limitations in assessment of whole body norepinephrine kinetics and plasma clearance". ''Am J Physiol'' 257: E743-E750, 1989. {{PMID|2596601}}
* Henriksen JH, Bendtsen F, Sørensen TIA, Stadeager C, Ring-Larsen H. "Reduced central blood volume in cirrhosis". ''Gastroenterology'' 97: 1506-1513, 1989. {{PMID|2583416}}
* Henriksen JH, Bendtsen F, Gerbes AL. "Splanchnic removal of alpha-atrial natriuretic peptide in humans: enhancement after food intake". ''Metabolism'' 39: 553-556, 1990. {{PMID|2139918}}
* Henriksen JH, Bendtsen F, Christensen NJ, Gerbes AL, Ring-Larsen H, Sørensen TIA. "Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade, and atrial natriuretic factor". ''Hepatology'' 16: 1163-1170, 1992. {{PMID|1358779}}
* Møller S, Emmeluth C, Henriksen JH. "Elevated circulatory plasma endothelin-1 concentration in cirrhosis". ''J Hepato''. 19: 285-290, 1993. {{PMID|8301063}}
* Møller S, Juul A, Becker U, Flyvbjerg A, Skakkebæk NE, Henriksen JH. "Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IFG-1, and growth hormone in different vascular beds in patients with cirrhosis". ''J Clin Endocrinol Metab'' 80: 1148-1157, 1995. {{PMID|7536200}}
* Gerbes AL, Møller S, Gülberg V, Paumgartner G, Henriksen JH. "Endothelin-1 and -3 plasma concentrations in patients with cirrhosis of the liver - role of splanchnic and renal passage and liver function". ''Hepatology'' 21: 735-739, 1995. {{PMID|7875671}}
* Møller S, Søndergaard L, Møgelvang J, Henriksen O, Henriksen JH. "Decreased right heart blood volume determined by magnetic resonance imaging: Evidence of central underfilling in cirrhosis". ''Hepatology'' 22: 472-478, 1995. {{PMID|7635415}}
* Møller S, Bendtsen F, Henriksen JH. "Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis". ''Gastroenterology'' 109: 1917-1925, 1995. {{PMID|7498657}}
* Bendtsen F, Henriksen JH. "Transit-time analysis in hepatic cirrhosis". ''Lancet'' 354: 598-599, 1999. {{PMID|10470729}}
* Henriksen JH, Holst JJ, Møller S, Brinch K, Bendtsen F. "Increased circulating leptin in cirrhosis: relation to release and disposal". ''Hepatology'' 29: 1818-1824, 1999. {{PMID|10347125}}
* Henriksen JH, Schifter S, Møller S, Bendtsen F. "Increased circulating calcitonin (CT) in cirrhosis. Relation to severity of disease and calcitonin gene-related peptide". ''Metabolism'' 49: 47-52, 2000. {{PMID|10647063}}
* Henriksen JH, Siemssen O, Krintel JJ., Malchow-Møller A, Bendtsen F, Ring-Larsen H. "Dynamics of albumin in plasma and ascitic fluid in patients with cirrhosis". ''J Hepatol'' 34: 53-60, 2001. {{PMID|11211908}}
* Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, Møller S. "Arterial compliance in patients with cirrhosis". ''Am J Physiol Gastrointest Liver Physiol'' 280: G584-594, 2001. {{PMID|11254484}}
* Møller S, Henriksen JH. "Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease". ''Heart'' 87:9-15, 2002. {{PMID|11751653}}
* Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, Møller S. "Dyssynchronous electrical and mechanical systole in patients with cirrhosis". ''J Hepatol'' 36:513-520 2002. {{PMID|11943423}}
* Henriksen JH, Gøtze JP, Fuglsang S, Christensen E, Bendtsen F, Møller S. "Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease". ''Gut'' 52:1511-1517, 2003. {{PMID|12970147}}
* Henriksen JH, Møller S, Fuglsang S, Bendtsen F. "Detection of early central circulatory transits in patients with cirrhosis by gamma variate fit of indicator dilution profiles". ''Am J Physiol''. GI 288: 677-684, 2005. {{PMID|15576626}}
* Henriksen JH, Fuglsang S, Bendtsen F, Møller S. "Arterial hypertension in cirrhosis. Arterial compliance, volume distribution, and central haemodynamics". ''Gut'' 55: 380-387, 2006. {{PMID|16474108}}
* Krag A, Bendtsen F, Henriksen JH, Møller S. "Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites". ''Gut'' 59:105-110, 2010. {{PMID|19837678}}
* Henriksen JH, Fuglsang S, Bendtsen F. "Fourier analysis of arterial pulse in patients with advanced cirrhosis indicates reduced wave reflections that may protect against manifest cardiac dysfunction". ''Gut'' 61: 1239-1240, 2012. {{PMID|22138534}}
* Zacho HD, Kristensen N, Henriksen JH, Abrahamsen J. "Validation of 99m technetium labelled mebrofenin hepatic extraction method to quantify meal induced splanchnic blood flow responses using a porcine model". ''J Appl Physiol'' 112: 877-882, 2012. {{PMID|22174389}}
* Henriksen JH, Jensen GB, Larsson HB. "A century of indicator dilution technique". ''Clin Physiol Funct Imaging'' 34: 1-9, 2014. {{PMID|23869947}}
* Henriksen UL, Kiszka-Kanowitz M, Bendtsen F, Henriksen JH. "Red blood cell (RBC) sodium transport in patients with cirrhosis". ''Clin Physiol Func Imaging'' 36: 359-367, 2016. {{PMID|26016736}}
* Henriksen UL, Kiszka-Kanowitz M, Bendtsen F, Henriksen JH. "Red blood cell (RBC) sodium transport in patients with cirrhosis". ''Clin Physiol Func Imaging'' 36: 359-367, 2016. {{PMID|26016736}} # Fuglsa''Clin Physiol Func Imaging'' 37: 588-595, 2017. {{PMID|26769593}}
Levende_personer